Zurcher Kantonalbank (Zurich Cantonalbank) - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$31,079
-55.5%
14,6600.0%0.00%
Q2 2023$69,782
-16.5%
14,6600.0%0.00%
Q1 2023$83,562
-43.5%
14,6600.0%0.00%
-100.0%
Q4 2022$147,919
-34.0%
14,660
+47.0%
0.00%0.0%
Q3 2022$224,000
-9.3%
9,9750.0%0.00%0.0%
Q2 2022$247,000
-36.2%
9,9750.0%0.00%
-50.0%
Q1 2022$387,000
-50.5%
9,975
-25.3%
0.00%
-50.0%
Q4 2021$782,000
+60.6%
13,360
+62.4%
0.00%
+33.3%
Q3 2021$487,000
-31.9%
8,225
-0.2%
0.00%
-25.0%
Q2 2021$715,000
+5.6%
8,238
+0.4%
0.00%0.0%
Q1 2021$677,000
-21.6%
8,206
-13.6%
0.00%
-20.0%
Q4 2020$864,000
+211.9%
9,497
+37.2%
0.01%
+150.0%
Q3 2020$277,000
+16.4%
6,9240.0%0.00%0.0%
Q2 2020$238,000
+107.0%
6,924
+33.7%
0.00%
+100.0%
Q1 2020$115,000
+101.8%
5,179
+76.5%
0.00%
Q4 2019$57,000
+23.9%
2,9340.0%0.00%
Q3 2019$46,000
-23.3%
2,9340.0%0.00%
-100.0%
Q2 2019$60,000
+15.4%
2,9340.0%0.00%
Q1 2019$52,000
+4.0%
2,934
-24.1%
0.00%
-100.0%
Q4 2018$50,000
+28.2%
3,865
+61.0%
0.00%
Q3 2018$39,0002,4010.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders